Major postpartum haemorrhage
Major postpartum haemorrhage
复制标题
DOI：
10.1097/00001703-200112000-00008
复制
发表时间：
2001-12-01
影响因子：
2.1
通讯作者：
Walkinshaw, S
中科院分区：
文献类型：
--
作者：
Mousa, HA;Walkinshaw, S
产后出血仍然是发达国家和发展中国家产妇死亡的前五大原因。持续失血超过1000毫升，应及时采取预定措施，以实现复苏和止血。给出了一个包含指导原则的协议，并讨论了卷替换。提出了对催产素和麦角新碱无反应的大出血的现代治疗可考虑的内科和外科干预措施的范围。该综述深入讨论了米索前列醇、重组激活因子VII、子宫填塞手术、动脉结扎和子宫止血缝合技术的应用。它还评估了介入放射学和子宫切除术在现代产科中的地位。
Postpartum haemorrhage remains in the top five causes of maternal deaths in both developed and developing countries. Persistent blood loss of more than 1000 ml should prompt predetermined measures to achieve resuscitation and haemostasis. A protocol including guidelines is given and volume replacement is discussed. The range of medical and surgical interventions that may be considered for the modern management of major haemorrhage unresponsive to oxytocin and ergometrine are presented. The review discusses in depth the use of misoprostol, recombinant activated factor VII, the uterine tamponade procedures, artery ligation, and uterine haemostatic suturing techniques. It also evaluates the place of interventional radiology and hysterectomy in modern obstetrics.